ISO 11607 splits the package from the process

A packaging validation file that stops once the pouch material has passed seal-strength and dye-penetration testing has finished about half the standard it's citing. ISO 11607, Packaging for terminally sterilized medical devices, is published in two parts on purpose, and the split isn't a formatting choice — it separates two different things that can each fail independently. Part 1 sets requirements for the sterile barrier system itself: the materials, the preformed system, and the design and performance testing that qualifies it as a system, not a material swatch. Part 2 covers something Part 1 never touches: whether the specific forming, sealing, and assembly process a manufacturer actually runs can reliably produce that qualified system, shift after shift, on the equipment it owns. A file that can point to a Part 1 test report and nothing else has proven the design works in a lab. It hasn't proven the line makes it.

Part 1 qualifies a system, not a swatch

ISO 11607-1:2019 sets requirements for materials, preformed sterile barrier systems, and packaging systems together — the standard tests the sterile barrier system as the device will actually ship, not a coupon of pouch stock in isolation. That means the device, the sterile barrier, and any protective packaging around it get evaluated as one assembly: seal strength, seal integrity, microbial barrier performance, and the physical and chemical properties the material has to hold onto through handling, sterilization, and shelf life. A manufacturer that qualifies a roll of medical-grade material against a generic data sheet, without running the actual system-level testing Part 1 requires for its own specific device and configuration, has confirmed the material is suitable in principle — not that this system, assembled this way, meets the standard.

Part 2 asks a completely different question

ISO 11607-2 doesn't re-test the system. It validates the process that makes it: the forming, sealing, and assembly steps a manufacturer's own equipment performs, under the manufacturer's own controlled parameters, at the manufacturer's own site. A sealing process validated to produce a Part-1-qualified system reliably, within defined process windows, is a separate deliverable from the system's own design testing — and a facility that changes its heat-sealer, its seal dwell time, or its production site can still be shipping the same qualified material and system while running an unvalidated process against it. Two manufacturers using the identical Part 1 test report on the identical film can arrive at completely different Part 2 outcomes, because Part 2 is validating equipment and parameters Part 1 never examined.

Accelerated aging buys a claim, not a proof

Neither part of ISO 11607 hands a manufacturer a shelf-life number. What supports an initial expiration date is typically accelerated aging under ASTM F1980, which uses an elevated-temperature protocol to simulate the effect of time on the sterile barrier system's integrity, compressing years into weeks. That protocol lets a sponsor make a tentative shelf-life claim early enough to support a launch timeline — but it's an estimate built on an aging-rate assumption, not a substitute for the real-time aging study that has to run in parallel and ultimately confirm it. A shelf-life file that stops at the accelerated data and never schedules the real-time study to catch up before the claimed expiration date is carrying a claim the standard's own logic never treated as final.

A change reopens one part, or both, depending what changed

Because Part 1 and Part 2 answer different questions, they don't always reopen together. Swapping the sterile barrier material, the pouch supplier, or the packaging configuration reopens Part 1 — the system itself has changed, and the design and performance testing that qualified the old one doesn't automatically transfer. Moving production to a new sealing line, changing seal temperature or dwell-time parameters, or relocating the assembly step to a new site reopens Part 2, even where the material and system design haven't moved at all. A packaging-change record that logs “packaging re-validated” without stating which part actually reran, and against which specific change, has recorded a conclusion without the traceability an auditor — or the process-validation clause this blog has already covered — expects to see behind it.

Where this meets the file

A packaging validation tracker built around this split needs four fields most templates collapse into one: the Part 1 system-level test report a given configuration relies on, the Part 2 process validation protocol and report for the specific line that makes it, the accelerated-aging interim claim and its assumed acceleration factor, and the real-time aging study's own completion date. Sterility itself sits downstream of this same discipline — a sterility assurance level is a probability the barrier has to actually hold, not a claim that survives on its own. A packaging validation worksheet built around ISO 11607's own two-part structure is previewed in the launch catalog. If your program tracks this differently, the shelf takes that correction directly.